These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence and impact of neuropsychiatric symptoms in normal aging and neurodegenerative syndromes: A population-based study from Latin America. Rodriguez Salgado AM; Acosta I; Kim DJ; Zitser J; Sosa AL; Acosta D; Jimenez-Velasquez IZ; Guerra M; Salas A; Valvuerdi A; Llibre-Guerra JC; Jeyachandran C; Contreras RL; Hesse H; Tanner C; Llibre Rodriguez JJ; Prina M; Llibre-Guerra JJ Alzheimers Dement; 2023 Dec; 19(12):5730-5741. PubMed ID: 37427840 [TBL] [Abstract][Full Text] [Related]
5. Burden in caregivers of primary care patients with dementia: influence of neuropsychiatric symptoms according to disease stage (NeDEM project). García-Martín V; de Hoyos-Alonso MC; Delgado-Puebla R; Ariza-Cardiel G; Del Cura-González I BMC Geriatr; 2023 Aug; 23(1):525. PubMed ID: 37644410 [TBL] [Abstract][Full Text] [Related]
6. Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. Wetzels RB; Zuidema SU; de Jonghe JF; Verhey FR; Koopmans RT Am J Geriatr Psychiatry; 2010 Dec; 18(12):1054-65. PubMed ID: 21155143 [TBL] [Abstract][Full Text] [Related]
7. The role of basket trials in drug development for neurodegenerative disorders. Cummings J; Montes A; Kamboj S; Cacho JF Alzheimers Res Ther; 2022 May; 14(1):73. PubMed ID: 35614479 [TBL] [Abstract][Full Text] [Related]
8. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study. Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181 [TBL] [Abstract][Full Text] [Related]
9. Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease. Cummings J; Zhong K Clin Pharmacol Ther; 2015 Nov; 98(5):483-5. PubMed ID: 26206713 [TBL] [Abstract][Full Text] [Related]
10. Together from the start: A transdiagnostic framework for early dyadic interventions for neurodegenerative diseases. Bannon SM; Grunberg VA; Manglani HR; Lester EG; Ritchie C; Vranceanu AM J Am Geriatr Soc; 2022 Jun; 70(6):1850-1862. PubMed ID: 35435998 [TBL] [Abstract][Full Text] [Related]
11. Advances in Management of Psychosis in Neurodegenerative Diseases. Rothenberg KG; Rajaram R Curr Treat Options Neurol; 2019 Jan; 21(1):3. PubMed ID: 30673880 [TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric symptoms in early stage of Alzheimer's and non-Alzheimer's dementia, and the risk of progression to severe dementia. Liew TM Age Ageing; 2021 Sep; 50(5):1709-1718. PubMed ID: 33770167 [TBL] [Abstract][Full Text] [Related]
13. The Symptoms Targeted for Monitoring in a Web-Based Tracking Tool by Caregivers of People With Dementia and Agitation: Cross-Sectional Study. Rockwood K; Sanon Aigbogun M; Stanley J; Wong H; Dunn T; Chapman CAT; Howlett SE; Miguelez M; McGarrigle L; Baker RA J Med Internet Res; 2019 Jun; 21(6):e13360. PubMed ID: 31254339 [TBL] [Abstract][Full Text] [Related]
14. New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin. Caraci F; Santagati M; Caruso G; Cannavò D; Leggio GM; Salomone S; Drago F F1000Res; 2020; 9():. PubMed ID: 32695312 [TBL] [Abstract][Full Text] [Related]
15. The role of the occupational therapist in the management of neuropsychiatric symptoms of dementia in clinical settings. Fraker J; Kales HC; Blazek M; Kavanagh J; Gitlin LN Occup Ther Health Care; 2014 Jan; 28(1):4-20. PubMed ID: 24354328 [TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. Aarsland D; Brønnick K; Ehrt U; De Deyn PP; Tekin S; Emre M; Cummings JL J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):36-42. PubMed ID: 16820421 [TBL] [Abstract][Full Text] [Related]
17. Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study. Alva G; Cubała WJ; Berrio A; Coate B; Abler V; Pathak S J Alzheimers Dis; 2024; 98(1):265-274. PubMed ID: 38427485 [TBL] [Abstract][Full Text] [Related]
18. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study. Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849 [TBL] [Abstract][Full Text] [Related]